\-\ Texto\\:\\ \ \(0\)\
\-\ treatment\\:\\ \ \(2\)\
\-\ grade\\ \\ \\ \\	\\	\\ \\ \\ \\ \\ \\ \\ \\ \\ \ \(0\)\
\-\ i\\-ii\\	initial\\ rx\\:\\ antibiotic\\ prophylaxis\ \(0\)\
\-\ \\_\\_\\_\\_follow\\ up\\ rx\\:\\ no\\ consensus\ \(0\)\
\-\ iii\\-iv\\	initial\\ rx\\:\\ antibiotic\\ prophylaxis\ \(0\)\
\-\ \\_\\_\\_\\_\\_\\_if\\ \\>6yrs\\ \\&\\ bilateral\\:\\ surgery\\	\\	\\ \ \(0\)\
\-\ \\_\\_\\_\\_\\_\\_follow\\ up\\ rx\\:\\ surgery\ \(0\)\
\-\ v\\	initial\\ rx\\:\\ \\<1yrs\\ \\-\\ antibiotic\\ prophylaxis\ \(0\)\
\-\ \\_\\_1\\-5yrs\\ \\&\\ unilateral\\:\\ antibiotic\\ prophylaxis\ \(0\)\
\-\ \\_\\_1\\-5yrs\\ \\&\\ bilateral\\ or\\ renal\\ scarring\\ present\\:\\ surgery\ \(0\)\
\-\ \\_\\_\\>6yrs\\:\\ surgery\ \(0\)\
\-\ \\_\\_follow\\ up\\ rx\\:\\ surgery\ \(0\)\
\-\ non\\ surgical\\ management\\ includes\\ urine\\ cultures\\ every\\ 4\\ months\\ \\&\\ when\\ febrile\\,\\ as\\ well\\ as\\ antibiotic\\ prophylaxis\\.\\ \\ amoxicillin\\ is\\ recommended\\ in\\ infants\\ less\\ than\\ 2\\ months\\ of\\ age\\,\\ trimethoprim\\-sulfamethoxazole\\ or\\ nitrofurantoin\\ in\\ children\\ greater\\ than\\ 2\\ months\\.\\ \\ if\\ vur\\ has\\ not\\ resolved\\ within\\ 12\\-18\\ months\\ or\\ breakthrough\\ pyelonephritis\\ occurs\\ while\\ on\\ prophylaxis\\,\\ surgical\\ correction\\ is\\ indicated\\.\ \(0\)\
\-\ vcug\\ findings\\:\ \(0\)\
\-\ early\\ filling\\ views\\ demonstrated\\ no\\ filling\\ defects\\ or\\ ureteroceles\\.\\ \\ there\ \(0\)\
\-\ was\\ bilateral\\ vesicoureteral\\ reflux\\ to\\ the\\ level\\ of\\ the\\ collecting\\ systems\\,\ \(1\)\
\-\ left\\ greater\\ than\\ right\\.\\ \\ there\\ was\\ mild\\ dilatation\\ of\\ the\\ collecting\\ system\ \(0\)\
\-\ as\\ well\\ as\\ blunting\\ of\\ the\\ calyces\\.\\ \\ the\\ patient\\ spontaneously\\ voided\\.\\ \ \(0\)\
\-\ post\\-void\\ images\\ continued\\ to\\ demonstrate\\ contrast\\ within\\ the\\ ureters\ \(0\)\
\-\ and\\ collecting\\ system\\ as\\ well\\ as\\ bladder\\.\ \(1\)\
\-\ \\ \ \(1082074\)\
\-\ impression\\:\ \(2\)\
\-\ bilateral\\ grade\\ iii\\ vesicoureteral\\ reflux\\,\\ slightly\\ worse\\ on\\ the\\ left\\.\ \(0\)\
\-\ vesicoureteral\\ reflux\\ \\(grade\\ iii\\)\ \(0\)\
\-\ 8\\ wk\\ old\\ female\\ with\\ left\\ renal\\ caliectasis\\ \\(8mm\\)\\ diagnosed\\ on\\ prenatal\\ us\\,\\ resolved\\ to\\ 6mm\\ on\\ us\\ at\\ 6wks\\ of\\ life\ \(0\)\
\-\ vesicoureteral\\ reflux\\(vur\\)\ \(0\)\
\-\ definition\\ \\â\\€\\“\\ retrograde\\ flow\\ of\\ urine\\ from\\ the\\ bladder\\ into\\ the\\ upper\\ urinary\\ tract\\.\ \(0\)\
\-\ grade\\ i\\ \\:\\ ureter\\ only\ \(0\)\
\-\ grade\\ ii\\:\\ ureter\\,\\ pelvis\\,\\ calyces\\;\\ no\\ dilation\\,\\ normal\\ calyceal\\ fornices\ \(0\)\
\-\ grade\\ iii\\:\\ \\ mild\\ dilation\\ of\\ ureter\\;\\ mild\\ or\\ moderate\\ dilation\\ of\\ the\\ pelvis\\,\\ but\\ minimal\\ blunting\\ of\\ the\\ fornices\\.\ \(0\)\
\-\ grade\\ iv\\:\\ moderate\\ dilation\\ of\\ the\\ ureter\\;\\ mild\\ dilation\\ of\\ renal\\ pelvis\\ and\\ calyces\\;\\ complete\\ obliteration\\ of\\ sharp\\ angle\\ of\\ fornices\\,\\ but\\ maintenance\\ of\\ papillary\\ impressions\\ in\\ majority\\ of\\ calyces\ \(0\)\
\-\ grade\\ v\\:\\ gross\\ dilation\\ and\\ tortuosity\\ of\\ ureter\\;\\ gross\\ dilation\\ of\\ renal\\ pelvis\\ and\\ calyces\\;\\ papillary\\ impressions\\ are\\ no\\ longer\\ visible\\ in\\ majority\\ of\\ calyces\ \(0\)\
\-\ significance\\ \\â\\€\\“\\ retrograde\\ flow\\ of\\ urine\\ from\\ the\\ bladder\\ to\\ the\\ upper\\ urinary\\ tract\\ facilitates\\ the\\ transport\\ of\\ bacteria\\.\\ \\ this\\ results\\ in\\ a\\ predisposition\\ to\\ pyelonephritis\\.\\ \\ multiple\\ episodes\\ of\\ pyelonephritis\\ leads\\ to\\ renal\\ scarring\\ resulting\\ in\\ complications\\ such\\ as\\ renal\\ insufficiency\\ and\\ hypertension\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ rx\\:\\ 0\\.2969383215100574\ \(0\)\
\-\ calyces\\:\\ 0\\.2718298803239806\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.2575656912102101\ \(0\)\
\-\ dilation\\:\\ 0\\.23984190766496594\ \(0\)\
\-\ grade\\:\\ 0\\.22398177065717242\ \(0\)\
\-\ ureter\\:\\ 0\\.19098272037440592\ \(0\)\
\-\ antibiotic\\:\\ 0\\.18218366666053512\ \(0\)\
\-\ vesicoureteral\\:\\ 0\\.16940187741627338\ \(0\)\
\-\ of\\:\\ 0\\.1600079396853561\ \(0\)\
\-\ fornices\\:\\ 0\\.15384145699085375\ \(0\)\
\-\ renal\\:\\ 0\\.14547590210054565\ \(0\)\
\-\ reflux\\:\\ 0\\.13488455709369737\ \(0\)\
\-\ iii\\:\\ 0\\.1344708829461994\ \(0\)\
\-\ 6yrs\\:\\ 0\\.12453138526378567\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.12129951638923518\ \(0\)\
\-\ impressions\\:\\ 0\\.11899638686891652\ \(0\)\
\-\ the\\:\\ 0\\.1165344329160357\ \(0\)\
\-\ collecting\\:\\ 0\\.10954421944130249\ \(0\)\
\-\ as\\:\\ 0\\.10949126555663898\ \(0\)\
\-\ pelvis\\:\\ 0\\.10892576666250875\ \(0\)\
\-\ vur\\:\\ 0\\.10560710075650369\ \(0\)\
\-\ surgery\\:\\ 0\\.10466576851167023\ \(0\)\
\-\ urine\\:\\ 0\\.1045556970894398\ \(0\)\
\-\ blunting\\:\\ 0\\.0911909407960567\ \(0\)\
\-\ months\\:\\ 0\\.09065350051962906\ \(0\)\
\-\ bladder\\:\\ 0\\.09064107955156978\ \(0\)\
\-\ mild\\:\\ 0\\.08828479286613665\ \(0\)\
\-\ bilateral\\:\\ 0\\.08370062655563464\ \(0\)\
\-\ retrograde\\:\\ 0\\.08329960831845089\ \(0\)\
\-\ scarring\\:\\ 0\\.0803202320085342\ \(0\)\
\-\ initial\\:\\ 0\\.07835745123688435\ \(0\)\
\-\ papillary\\:\\ 0\\.07256669003021554\ \(0\)\
\-\ majority\\:\\ 0\\.07072490835017356\ \(0\)\
\-\ resolved\\:\\ 0\\.06995200463752427\ \(0\)\
\-\ gross\\:\\ 0\\.06910233576876315\ \(0\)\
\-\ or\\:\\ 0\\.06772413077783222\ \(0\)\
\-\ urinary\\:\\ 0\\.06733846826934489\ \(0\)\
\-\ than\\:\\ 0\\.0662135946496025\ \(0\)\
\-\ tract\\:\\ 0\\.06523415954252777\ \(0\)\
\-\ \\_\\_\\_\\_follow\\:\\ 0\\.062265692631892834\ \(0\)\
\-\ \\_\\_\\_\\_\\_\\_if\\:\\ 0\\.062265692631892834\ \(0\)\
\-\ \\_\\_\\_\\_\\_\\_follow\\:\\ 0\\.062265692631892834\ \(0\)\
\-\ 1yrs\\:\\ 0\\.062265692631892834\ \(0\)\
\-\ \\_\\_\\:\\ 0\\.062265692631892834\ \(0\)\
\-\ \\_\\_follow\\:\\ 0\\.062265692631892834\ \(0\)\
\-\ voided\\:\\ 0\\.062265692631892834\ \(0\)\
\-\ us\\:\\ 0\\.06194205975220812\ \(0\)\
\-\ ii\\:\\ 0\\.06139594750125222\ \(0\)\
\-\ filling\\:\\ 0\\.060303285642970154\ \(0\)\
\-\ caliectasis\\:\\ 0\\.05949819343445826\ \(0\)\
\-\ system\\:\\ 0\\.05940683764969049\ \(0\)\
\-\ moderate\\:\\ 0\\.05845730670376707\ \(0\)\
\-\ to\\:\\ 0\\.05840218317967546\ \(0\)\
\-\ in\\:\\ 0\\.058114727755020176\ \(0\)\
\-\ up\\:\\ 0\\.057779172671000134\ \(0\)\
\-\ nitrofurantoin\\:\\ 0\\.05753462150507233\ \(0\)\
\-\ ureteroceles\\:\\ 0\\.05753462150507233\ \(0\)\
\-\ 6wks\\:\\ 0\\.05753462150507233\ \(0\)\
\-\ facilitates\\:\\ 0\\.05753462150507233\ \(0\)\
\-\ greater\\:\\ 0\\.05736879597390548\ \(0\)\
\-\ well\\:\\ 0\\.056557694374334624\ \(0\)\
\-\ iv\\:\\ 0\\.05563969652065862\ \(0\)\
\-\ amoxicillin\\:\\ 0\\.05199962311020318\ \(0\)\
\-\ wk\\:\\ 0\\.05199962311020318\ \(0\)\
\-\ flow\\:\\ 0\\.051867052128260045\ \(0\)\
\-\ breakthrough\\:\\ 0\\.05128048566361791\ \(0\)\
\-\ no\\:\\ 0\\.050644999068090724\ \(0\)\
\-\ transport\\:\\ 0\\.05062994671256852\ \(0\)\
\-\ predisposition\\:\\ 0\\.05062994671256852\ \(0\)\
\-\ tortuosity\\:\\ 0\\.049489720251676236\ \(0\)\
\-\ consensus\\:\\ 0\\.0489838968174087\ \(0\)\
\-\ maintenance\\:\\ 0\\.048512986466183336\ \(0\)\
\-\ calyceal\\:\\ 0\\.04807247925143134\ \(0\)\
\-\ 8mm\\:\\ 0\\.04765868632852218\ \(0\)\
\-\ on\\:\\ 0\\.047036267647295314\ \(0\)\
\-\ obliteration\\:\\ 0\\.04502634982216348\ \(0\)\
\-\ vcug\\:\\ 0\\.04401331013802257\ \(0\)\
\-\ significance\\:\\ 0\\.04378191533936284\ \(0\)\
\-\ 6mm\\:\\ 0\\.04334140812461085\ \(0\)\
\-\ bacteria\\:\\ 0\\.04313137638831344\ \(0\)\
\-\ definition\\:\\ 0\\.042927615201701685\ \(0\)\
\-\ ureters\\:\\ 0\\.042350469354068346\ \(0\)\
\-\ upper\\:\\ 0\\.04161262325012183\ \(0\)\
\-\ infants\\:\\ 0\\.04057390892717627\ \(0\)\
\-\ and\\:\\ 0\\.040227303203312956\ \(0\)\
\-\ febrile\\:\\ 0\\.04002757799803524\ \(0\)\
\-\ correction\\:\\ 0\\.04002757799803524\ \(0\)\
\-\ left\\:\\ 0\\.03984482993775776\ \(0\)\
\-\ spontaneously\\:\\ 0\\.0396447397442936\ \(0\)\
\-\ longer\\:\\ 0\\.0396447397442936\ \(0\)\
\-\ leads\\:\\ 0\\.03928223901120207\ \(0\)\
\-\ but\\:\\ 0\\.03850693034860613\ \(0\)\
\-\ prenatal\\:\\ 0\\.03840030526149295\ \(0\)\
\-\ sharp\\:\\ 0\\.03829766433702064\ \(0\)\
\-\ impression\\:\\ 0\\.037901872724377214\ \(0\)\
\-\ surgical\\:\\ 0\\.03784745218262218\ \(0\)\
\-\ every\\:\\ 0\\.03771226350811166\ \(0\)\
\-\ systems\\:\\ 0\\.03761939822724785\ \(0\)\
\-\ insufficiency\\:\\ 0\\.03752777949790841\ \(0\)\
\-\ cultures\\:\\ 0\\.03667347936024726\ \(0\)\
\-\ within\\:\\ 0\\.03586460800617354\ \(0\)\
\-\ unilateral\\:\\ 0\\.03563280606405837\ \(0\)\
\-\ episodes\\:\\ 0\\.03556420756852249\ \(0\)\
\-\ visible\\:\\ 0\\.034319773085721844\ \(0\)\
\-\ angle\\:\\ 0\\.03415123383497037\ \(0\)\
\-\ defects\\:\\ 0\\.03356659321020015\ \(0\)\
\-\ worse\\:\\ 0\\.032617079771263886\ \(0\)\
\-\ resulting\\:\\ 0\\.032398994355149764\ \(0\)\
\-\ indicated\\:\\ 0\\.03202318423951263\ \(0\)\
\-\ life\\:\\ 0\\.031942408233426756\ \(0\)\
\-\ children\\:\\ 0\\.03190237590252385\ \(0\)\
\-\ continued\\:\\ 0\\.03190237590252385\ \(0\)\
\-\ dilatation\\:\\ 0\\.03178366868694699\ \(0\)\
\-\ there\\:\\ 0\\.03098430670029121\ \(0\)\
\-\ recommended\\:\\ 0\\.03097102987610406\ \(0\)\
\-\ from\\:\\ 0\\.03092673788242271\ \(0\)\
\-\ views\\:\\ 0\\.030731514323538437\ \(0\)\
\-\ occurs\\:\\ 0\\.03069797375062611\ \(0\)\
\-\ slightly\\:\\ 0\\.030371332820116784\ \(0\)\
\-\ results\\:\\ 0\\.030339512282983604\ \(0\)\
\-\ includes\\:\\ 0\\.03027631282355721\ \(0\)\
\-\ complications\\:\\ 0\\.02982009675756108\ \(0\)\
\-\ hypertension\\:\\ 0\\.029790739753797667\ \(0\)\
\-\ minimal\\:\\ 0\\.029703418824845246\ \(0\)\
\-\ management\\:\\ 0\\.028759541786504066\ \(0\)\
\-\ diagnosed\\:\\ 0\\.028203530678669483\ \(0\)\
\-\ early\\:\\ 0\\.028065637244267416\ \(0\)\
\-\ complete\\:\\ 0\\.027292113112692133\ \(0\)\
\-\ was\\:\\ 0\\.02713853196206424\ \(0\)\
\-\ less\\:\\ 0\\.026488185844643478\ \(0\)\
\-\ while\\:\\ 0\\.02516297535575696\ \(0\)\
\-\ such\\:\\ 0\\.025045037339803705\ \(0\)\
\-\ age\\:\\ 0\\.024443837909171682\ \(0\)\
\-\ only\\:\\ 0\\.024324438488041507\ \(0\)\
\-\ demonstrated\\:\\ 0\\.023928461649198172\ \(0\)\
\-\ when\\:\\ 0\\.023519050127650175\ \(0\)\
\-\ level\\:\\ 0\\.023519050127650175\ \(0\)\
\-\ if\\:\\ 0\\.022622257578737703\ \(0\)\
\-\ is\\:\\ 0\\.021325280421847587\ \(0\)\
\-\ into\\:\\ 0\\.0206972260840653\ \(0\)\
\-\ demonstrate\\:\\ 0\\.02024127657120425\ \(0\)\
\-\ present\\:\\ 0\\.019978861670251986\ \(0\)\
\-\ findings\\:\\ 0\\.01921603093319698\ \(0\)\
\-\ multiple\\:\\ 0\\.019044002205378417\ \(0\)\
\-\ contrast\\:\\ 0\\.018917767563780552\ \(0\)\
\-\ female\\:\\ 0\\.018787979000829676\ \(0\)\
\-\ treatment\\:\\ 0\\.018546851571328283\ \(0\)\
\-\ non\\:\\ 0\\.018473910961775895\ \(0\)\
\-\ images\\:\\ 0\\.018010073467893226\ \(0\)\
\-\ has\\:\\ 0\\.017784416788825554\ \(0\)\
\-\ normal\\:\\ 0\\.01589693809852198\ \(0\)\
\-\ not\\:\\ 0\\.015370649221694354\ \(0\)\
\-\ are\\:\\ 0\\.014774097683870505\ \(0\)\
\-\ at\\:\\ 0\\.0147062781763351\ \(0\)\
\-\ this\\:\\ 0\\.013378799705087539\ \(0\)\
\-\ right\\:\\ 0\\.012908594867620905\ \(0\)\
\-\ patient\\:\\ 0\\.012663631722326126\ \(0\)\
\-\ old\\:\\ 0\\.011523222004587963\ \(0\)\
\-\ with\\:\\ 0\\.007623978304342397\ \(0\)\
